Using the data from the case, calculate the ratios for Hexo in 2016 and 2017. Show your work and the result. Sales growthn/a Gross Profit Margin Operating Profit Margin Current Ratio Debt to Equity Ratio Inventory Turnover Age of Accounts Receivable

 

Transcribed Image Text:

Page 11 EXHIBIT 4: HEXO STATEMENTS OF FINANCIAL POSITION, 2017-2018 (IN CA$) As at July 31 ASSETS Current Assets Cash and Cash Equivalents Short-Term Investment Share Subscriptions Receivable Accounts Receivable Commodity Taxes Recoverable Prepaid Expenses Inventory Biological Assets* Total Current Assets Fixed Assets Property, Plant, and Equipment Intangible Assets Less: Accumulated Depreciation & Amortization Total Fixed Assets Total Assets Liabilities and Shareholders' Equity Liabilities Current Liabilities Accounts Payable and Accrued Liabilities Commodity Taxes Payable Warrant Liability Total Current Liabilities Long-Term Liabilities Unsecured Convertible Debentures Total Liabilities Shareholders' Equity Share Capital Share-Based Payment Reserve Contributed Surplus Warrants Deficit Total Shareholders' Equity Total Liabilities & Shareholders' Equity 2017 $ 38,452,823 2,871,550 351,207 495,783 200,677 3,689,239 1,504,186 $ 47,565,465 6,336,177 3,195,943 (918,661) 8,613,459 $ 56,178,924 1,672,406 1,355,587 $ 3,027,993 20,711,441 $ 23,739,434 $ 45,159,336 1,561,587 1,774,880 3,728,255 (19,784,568) $ 32,439,490 $ 56,178,924 9B20B00 Note: * Biological assets = Cannabis plants on hand in HEXO's production facilities. Source: Company files. 2016 $ 1,931,454 250,011 1,043,365 27,425 35,737 531,425 120,667 $ 3,940,084 3,118,525 2,840,856 (389,389) 5,569,992 $ 9,510,076 1,373,499 43,863 $ 1,417,362 $ 306,205 $ 1,723,567 $12,756,262 937,065 89,601 1,370,579 (7,366,998) $ 7,786,509 $ 9,510,076 Page 11 EXHIBIT 4: HEXO STATEMENTS OF FINANCIAL POSITION, 2017-2018 (IN CA$) As at July 31 ASSETS Current Assets Cash and Cash Equivalents Short-Term Investment Share Subscriptions Receivable Accounts Receivable Commodity Taxes Recoverable Prepaid Expenses Inventory Biological Assets* Total Current Assets Fixed Assets Property, Plant, and Equipment Intangible Assets Less: Accumulated Depreciation & Amortization Total Fixed Assets Total Assets Liabilities and Shareholders' Equity Liabilities Current Liabilities Accounts Payable and Accrued Liabilities Commodity Taxes Payable Warrant Liability Total Current Liabilities Long-Term Liabilities Unsecured Convertible Debentures Total Liabilities Shareholders' Equity Share Capital Share-Based Payment Reserve Contributed Surplus Warrants Deficit Total Shareholders' Equity Total Liabilities & Shareholders' Equity 2017 $ 38,452,823 2,871,550 351,207 495,783 200,677 3,689,239 1,504,186 $ 47,565,465 6,336,177 3,195,943 (918,661) 8,613,459 $ 56,178,924 1,672,406 1,355,587 $ 3,027,993 20,711,441 $ 23,739,434 $ 45,159,336 1,561,587 1,774,880 3,728,255 (19,784,568) $ 32,439,490 $ 56,178,924 9B20B00 Note: * Biological assets = Cannabis plants on hand in HEXO's production facilities. Source: Company files. 2016 $ 1,931,454 250,011 1,043,365 27,425 35,737 531,425 120,667 $ 3,940,084 3,118,525 2,840,856 (389,389) 5,569,992 $ 9,510,076 1,373,499 43,863 $ 1,417,362 $ 306,205 $ 1,723,567 $12,756,262 937,065 89,601 1,370,579 (7,366,998) $ 7,786,509 $ 9,510,076

Answer rating: 100% (QA)

Sure lets calculate the requested ratios using the provided financial data for Hexo in 2016 and 2017 1 Sales Growth 2016 Sales 38452823 2017 Sales 475... View the full answer